... changes include an increase in mitochondrial number, increased muscle capillarization, and an increase inmuscle oxidative enzyme activity After intense training the proportion of type I fibers increases, ... successful in increasing lean body mass in patients with COPD In one study [67] an increase in the creatine phosphate/ creatine phosphate + creatine ratio (measured from quadriceps muscle biopsy) ... Deconditioning from disuse is believed to be a major contributing factor in the skeletal muscledysfunction that is observed in patients with COPD Therefore, exercise training in this setting should...
... exacerbators Decline in QMVC in this cohort was not associated with disease severity, having frequent exacerbations or corticosteroid treatment Change in fat free mass during follow up Decline in FFM was ... difference in the results obtained In addition it was possible in most patients to correlate their reports of exacerbations with the medical notes relating to clinic attendances in the intervening year ... significantly greater decline in FFM in this group Maintenance therapy has been shown to attenuate the improvement inmuscle bulk occurring with nutritional supplementation during pulmonary rehabilitation...
... in healthy individuals [18,19] In COPD, the abdominal muscles are frequently recruited even during resting breathing [20] When walking to exhaustion, inspiratory work of breathing in COPD rises ... case in normal subjects, in whom the distinction into inspiratory and expiratory is not absolute During exercise, at least in normal subjects, the expiratory muscles act as accessory muscles of inspiration ... resistant muscle fibres, or because muscle shortening due to lung hyperinflation protects against fatigue [42] Conversely abdominal muscles lengthen during hyperinflation potentially rendering them...
... baseline (Baseline Dyspnea Index) in order to answer questions regarding the TDI [28] Therefore, we used the MMRC scale which is a traditional instrument included in the BODE index [20] In multiple ... follow-up This finding reinforces the impact of exacerbation in clinical outcomes; exacerbations of COPD indicate clinical instability and progression of the disease and are associated with increased ... (SGRQ) in patients with chronicobstructivediseasein Brazil J Bras Pneumol 2000, 26: 119-125 17 Jones PW: Interpreting thresholds for a clinically significant change in health status in asthma...
... Organization: Chronicobstructivepulmonary disease. [http:// www.who.int/mediacentre/factsheets/fs315/en/index.html], Accessed February 10, 2011 Global Initiative for ChronicObstructive Lung Disease: ... less efficient at discriminating between COPD stages (RE < 1) (Table 2) For the purpose of discriminating among COPD patients according to stage of disease, results indicated that only the SGRQ ... in studies of other conditions [28-30] Inperipheral arterial disease, the disease- specific Vascular Quality of Life (VascuQol) measure was more discriminative than the EQ-5D and SF-36 [28] In...
... concentrations of pro-inflammatory cytokines, including interleukin-1 (IL-1), interleukin-6 (IL-6), interleukin-8 (IL-8), and tumour necrosis factor-alpha (TNFalpha) were measured using quantitative ... Jansen HM, Lutter R: Persisting Haemophilus influenzae strains induce lower levels of interleukin-6 and interleukin-8 in H292 lung epithelial cells than nonpersisting strains Eur Respir J 1997, 10:2319-2326 ... determinants of exacerbation inchronicobstructivepulmonarydisease Arch Intern Med 2005, 165:891-897 Miravitlles M: Exacerbations of chronicobstructivepulmonary disease: when are bacteria...
... COPD stages [10] In contrast, an inverse association between higher levels of circulating inflammation-sensitive proteins, including CRP, interleukin (IL)-6 and alpha-1 antitrypsin (A1AT), and ... ageing rate and longevity FEBS Lett 2005, 579:2035-2039 Ben-Zaken Cohen S, Paré PD, Man SFP, Sin DD: The growing burden of chronicobstructivepulmonarydisease and lung cancer in women Examining ... on systemic biomarkers of inflammation inchronicobstructivepulmonarydisease Am J Respir Crit Care Med 2008, 177:1207-1214 Barnes PJ: Chronicobstructivepulmonarydisease N Engl J Med 2000,...
... to inhaled corticosteroids prior to screening † Data missing for four patients in ACCLAIM/COPD I (two each in the aclidinium and placebo arms) BMI: body mass index; COPD: chronicobstructivepulmonary ... 350 400 COPD: chronicobstructivepulmonarydisease Figure Kaplan-Meier survival curves for the time to first moderate or severe chronicobstructivepulmonarydisease exacerbation in ACCLAIM/COPD ... Garcia GE, Ferrer P: Safety and pharmacokinetics of single doses of aclidinium bromide, a novel long-acting, inhaled antimuscarinic, in healthy subjects Int J Clin Pharmacol Ther 2009, 47:460-468 Chanez...
... 30-minute periods of cycling exercises, walking, and inspiratory muscle training each The cycling protocol consisted of intervals of one minute loaded cycling (aimed at 140% of a patient’s initial ... and one minute unloaded cycling, during 30 minutes [14] Inspiratory muscle training was performed on an inspiratory threshold device at an interval basis (two minutes of loaded breathing, followed ... Global Initiative for ChronicObstructive Lung Disease (GOLD) 2010 [http://www.goldcopd.org] Lacasse Y, Goldstein R, Lasserson TJ, Martin S: Pulmonary rehabilitation for chronicobstructive pulmonary...
... Longitudinal average Wheezing Baseline Longitudinal average Nighttime Symptom Scores Difficulty breathing Baseline Longitudinal average Coughing Baseline Longitudinal average Wheezing Baseline Longitudinal ... Care Med 2007, 176(6):532– 555 Chronicobstructivepulmonarydisease National clinical guideline on management of chronicobstructivepulmonarydiseasein adults in primary and secondary care ... treatment with inhaled budesonide in persons with mild chronicobstructivepulmonarydisease who continue smoking European Respiratory Society Study on ChronicObstructivePulmonaryDisease N Engl...
... staining in the both alveolar wall and alveolar Figure Lung sections stained for elastin, versican and elastin binding protein Lung sections stained for elastin, versican and elastin binding ... Figure Relationship between elastin binding protein and elastin Relationship between elastin binding protein and elastin Relationship between EBP immuno-staining intensities for alveolar wall (a) ... elastin receptor: a galactosidase-binding protein Science 1988, 239:1539-1541 Mecham RP, Whitehouse L, Hay M, Hinek A, Sheetz MP: Ligand affinity of the 67-kDa elastin/laminin binding protein is...
... [http://WWW.thoracic.org/COPD/1/definitions.asp]: Jeffery PK: Remodeling and inflammation of bronchi in asthma and chronicobstructivepulmonarydisease Proc Am Thorac Soc 2004, 1(3):176-183 Cosio MG, Guerassimov A: Chronicobstructive ... decline inchronicobstructivepulmonarydisease Thorax 2002, 57(10):847-852 Hurst JR, Perera WR, Wilkinson TM, Donaldson GC, Wedzicha JA: Exacerbation of chronicobstructivepulmonary disease: ... the accumulating evidence of extra pulmonary manifestations in COPD including cachexia and systemic inflammation which are observed in severe COPD patients In our model of acute inflammation...
... (use in epidemiology) Scand J Respir Dis 1972, 53:218-226 Global initiative for ChronicObstructive Lung Disease NIH: Definitions chapter in Global Initiative for ChronicObstructive Lung Disease ... Simony-Lafontaine J, Lequeu N, Vic P, Enander I, Godard P, Michel FB: Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronicobstructivepulmonarydisease J Allergy Clin Immunol ... airways), which may be insufficient to obtain a full view Fourth, remodelling in COPD may itself generate and maintain an inflammatory process, independent of cigarette smoking [25] In order to elucidate...
... Atochina EN, Morris KG, Danilov SM, Stenmark KR: Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension J Clin Invest ... Studies of pulmonary hypertension I Pulmonary circulatory dynamics in patients with pulmonary emphysema at rest J Clin Invest 1953, 32(2):130-7 Heath D: Remodeling of the pulmonary vasculature in hypoxic ... in particular no significant effect on arterial blood gases The rationale behind this study was based on the findings that angiotensin converting enzyme and angiotensin II are both involved in...
... to maintain a constant Pappl, a change in any one of its determinants (Pmus or Paw) must be met by an opposite change in the other In clinical terms, this means that, for instance, increasing ... patient with severe chronicobstructivepulmonarydisease Intensive Care Med 1998, 24:898-910 Sethi J, Siegel M: Mechanical ventilation inchronicobstructive lung disease Clin Chest Med 2000, ... ventilation on inspiratory muscle effort in patients with chronicobstructivepulmonarydisease and acute respiratory failure Anesthesiology 1997, 86:79-91 43 Wrigge H, Golisch W, Zinserling J, Sydow...
... Rabe KF, Goehring U-M, Kristiansen S, Fabbri LM, Martinez FJ; for the M2-124 and M2-125 Study Groups: Roflumilast in symptomatic chronicobstructivepulmonary disease: two randomised clinical trials ... Groups: Roflumilast in moderate-to-severe chronicobstructivepulmonarydisease treated with longacting bronchodilators: two randomised clinical trials Lancet 2009, 374: 695-703 Reichlin T, Hochholzer ... G, Guérin C: Six-month outcome in acute kidney injury requiring renal replacement therapy in the ICU: a multicentre prospective study Intensive Care Med 2009, in press Whitcomb DC: Clinical practice:...
... combined with FBO in COPD with hypercapnic encephalopathy) in the most challenging patients Abbreviations COPD, chronicobstructivepulmonary disease; FBO, fibreoptic bronchoscopy; NPPV, noninvasive ... closely monitored in an intensive care unit setting and, if there is no improvement in gas exchange or vital signs within the first to hours, intubation should be planned with no delay in the best conditions ... ventilation in patients with decompensated chronicobstructivepulmonarydisease due to community-acquired-pneumonia Crit Care 2010, 14:R80 Robert D, Argaud L: Clinical review: long-term noninvasive...
... A, Marinari S: Systemic effects of COPD Respir Med 2005, 99(Suppl B):S3-10 Jagoe RT, Engelen MP: Muscle wasting and changes inmuscle protein metabolism inchronicobstructivepulmonarydisease ... anterior muscle of patients with COPD [10] This is in line with previous studies [3,7-9] and together with previous findings of a decrease in oxidative enzyme activities in COPD [6,7] our findings indicate ... alterations in the capillary bed of skeletal musclein COPD patients Extending these findings the current study provides first evidence of a disturbed muscle- to-capillary interface expressed as CFPE-index...
... of chronicobstructivepulmonarydisease worldwide Monaldi Archives for Chest Disease 2001; 56: 261-264 Anto JM, Vermeire P, Vestbo J, Sunyer J Epidemiology of chronicobstructivepulmonarydisease ... Int J Med Sci 2007, disease [5] How we account for these increases in rates of COPD? Chronicobstructivepulmonarydisease (COPD) is a condition characterized ... (accounting for approximately one-sixth of the patient population in California), and data on patients insured at Shriner Hospital However, these insurance companies are located in urban areas in...
... symptom in the development of chronicobstructivepulmonarydisease [21,22] There is evidence that a reduction in air pollutants attenuates the decline in respiratory health in children The delay in ... baseline, pt prevalence at followup, E baseline exposure at baseline, ΔE exposure decline (exposure at baseline minus exposure at follow-up), t follow-up time, Sbaseline smoking at baseline (yes ... lung aging was accelerated in the highly polluted areas at baseline The results at follow up demonstrate that the increase in lung aging in these areas was attenuated due to a steep decline in air...